0000939767-18-000179.txt : 20180809 0000939767-18-000179.hdr.sgml : 20180809 20180809193505 ACCESSION NUMBER: 0000939767-18-000179 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180807 FILED AS OF DATE: 20180809 DATE AS OF CHANGE: 20180809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MORRISSEY MICHAEL CENTRAL INDEX KEY: 0001202096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 181006772 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY CITY: SAN FRANCISCO STATE: CA ZIP: 94083 FORMER NAME: FORMER CONFORMED NAME: MORRISSEY MICHAEL M DATE OF NAME CHANGE: 20030512 FORMER NAME: FORMER CONFORMED NAME: MORRISSEY MICHAEL R DATE OF NAME CHANGE: 20021029 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1228 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_153385768970246.xml FORM 4 X0306 4 2018-08-07 0 0000939767 EXELIXIS, INC. EXEL 0001202096 MORRISSEY MICHAEL C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 1 1 0 0 President and CEO Common Stock 2018-08-07 4 M 0 100000 1.70 A 225000 D Common Stock 2018-08-07 4 S 0 100000 21.10 D 125000 D Common Stock 2018-08-08 4 M 0 100000 1.70 A 225000 D Common Stock 2018-08-08 4 S 0 100000 21.02 D 125000 D Common Stock 2018-08-09 4 M 0 34267 1.70 A 159267 D Common Stock 2018-08-09 4 S 0 34267 20.91 D 125000 D Common Stock 176351 I By Trust Common Stock 17354 I By 401(k) Option (right to buy) 1.7 2018-08-07 4 M 0 100000 0 D 2015-07-20 2021-09-18 Common Stock 100000.0 704551 D Option (right to buy) 1.7 2018-08-08 4 M 0 100000 0 D 2015-07-20 2021-09-18 Common Stock 100000.0 604551 D Option (right to buy) 1.7 2018-08-09 4 M 0 34267 0 D 2015-07-20 2021-09-18 Common Stock 34267.0 570284 D Includes 125,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.00 to $21.22. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.95 to $21.15. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.90 to $20.95. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 8, 2018. The option, representing the right to purchase a total of 1,125,000 shares of Exelixis, Inc. common stock, became exercisable as to fifty percent (50%) of the shares subject to the option on July 20, 2015, as to twenty-five (25%) of the shares subject to the option on March 7, 2016 and as to the remaining twenty-five (25%) of the shares subject to the option on April 28, 2016. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2018-08-09